WallStSmart

High Tide Inc (HITI)vsPOMDOCTOR LIMITED American Depositary Shares (POM)

VS

Smart Verdict

WallStSmart Research — data-driven comparison

High Tide Inc generates 72% more annual revenue ($629.85M vs $366.86M). HITI leads profitability with a -7.4% profit margin vs -40.6%. HITI earns a higher WallStSmart Score of 30/100 (F).

HITI

Avoid

30

out of 100

Grade: F

Growth: 6.0Profit: 3.5Value: 5.0Quality: 4.5
Piotroski: 1/9Altman Z: 0.68

POM

Avoid

28

out of 100

Grade: F

Growth: 6.7Profit: 2.5Value: 5.0Quality: 5.0
Piotroski: 4/9Altman Z: -66.56

Key Strengths & Concerns

Side-by-side fundamental analysis

Key Strengths

HITI1 strengths · Avg: 8.0/10
Revenue GrowthGrowth
25.2%8/10

Revenue surging 25.2% year-over-year

POM2 strengths · Avg: 9.0/10
Debt/EquityHealth
-0.1910/10

Conservative balance sheet, low leverage

Revenue GrowthGrowth
16.2%8/10

16.2% revenue growth

Areas to Watch

HITI4 concerns · Avg: 3.0/10
Market CapQuality
$196.76M3/10

Smaller company, higher risk/reward

Operating MarginProfitability
2.3%3/10

Operating margin of 2.3%

Debt/EquityHealth
1.713/10

Elevated debt levels

Piotroski F-ScoreQuality
1/93/10

Weak financial health signals

POM4 concerns · Avg: 3.0/10
EPS GrowthGrowth
0.0%4/10

0.0% earnings growth

Market CapQuality
$40.13M3/10

Smaller company, higher risk/reward

Return on EquityProfitability
0.0%3/10

ROE of 0.0% — below average capital efficiency

Free Cash FlowQuality
$-16.17M2/10

Negative free cash flow — burning cash

Comparative Analysis Report

WallStSmart Research

Bull Case : HITI

The strongest argument for HITI centers on Revenue Growth. Revenue growth of 25.2% demonstrates continued momentum.

Bull Case : POM

The strongest argument for POM centers on Debt/Equity, Revenue Growth. Revenue growth of 16.2% demonstrates continued momentum.

Bear Case : HITI

The primary concerns for HITI are Market Cap, Operating Margin, Debt/Equity. Debt-to-equity of 1.71 is elevated, increasing financial risk.

Bear Case : POM

The primary concerns for POM are EPS Growth, Market Cap, Return on Equity.

Key Dynamics to Monitor

HITI is growing revenue faster at 25.2% — sustainability is the question.

HITI generates stronger free cash flow (4M), providing more financial flexibility.

Monitor PHARMACEUTICAL RETAILERS industry trends, competitive dynamics, and regulatory changes.

Bottom Line

HITI scores higher overall (30/100 vs 28/100) and 25.2% revenue growth. Both earn "Avoid" and "Avoid" ratings respectively — the choice depends on your investment horizon and risk tolerance.

This analysis is generated from publicly available financial data. Not financial advice.

High Tide Inc

HEALTHCARE · PHARMACEUTICAL RETAILERS · USA

High Tide Inc. is a vertically integrated company in the cannabis market in Canada, the United States and internationally. The company is headquartered in Calgary, Canada.

Visit Website →

POMDOCTOR LIMITED American Depositary Shares

HEALTHCARE · PHARMACEUTICAL RETAILERS · USA

Pomdoctor Limited, offers an online B2C portal to sell pharmaceutical products. The company is headquartered in Guangzhou, China.

Visit Website →

Want to dig deeper into these stocks?